Home / Dabigatran Etexilate / Canada
CA ATC B01AE07 · updated 2 Nov 2026
Dabigatran Etexilate shortage in Canada
Is there a Dabigatran Etexilate shortage in Canada?
Yes. As of 2 Nov 2026, 2 Dabigatran Etexilate products are reported short in Canada, the first since 22 Oct 2024. No return date has been given. Main reason: manufacturing problem.
Also short in Germany, Italy, Spain, Austria, Belgium, Czechia, Norway, Sweden, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO-DABIGATRAN (60 BLS) | APOTEX INC | 22 Oct 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DABIGATRAN (60 BLS) | APOTEX INC | 12 Nov 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.